Genetic factors in ovarian carcinoma
- 1 February 2001
- journal article
- research article
- Published by Springer Nature in Current Oncology Reports
- Vol. 3 (1) , 27-32
- https://doi.org/10.1007/s11912-001-0039-y
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian CancersThe American Journal of Pathology, 2000
- Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage ResponseScience, 1999
- Mutation of thePTENTumor Suppressor Gene Is Not a Feature of Ovarian CancersGynecologic Oncology, 1998
- Studies on the molecular mechanism of growth inhibition with p53 adenoviral construct in human ovarian cancerInternational Journal of Gynecologic Cancer, 1998
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneNature Genetics, 1997
- BRCA1 is secreted and exhibits properties of a graninNature Genetics, 1996
- Growth retardation and tumour inhibition by BRCA1Nature Genetics, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Overexpression of p53 Is Not a Feature of Benign and Early-Stage Borderline Epithelial Ovarian TumorsGynecologic Oncology, 1994